BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27722867)

  • 1. Immunology of Yersinia pestis Infection.
    Bi Y
    Adv Exp Med Biol; 2016; 918():273-292. PubMed ID: 27722867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of immune response in Yersinia pestis infection.
    Amedei A; Niccolai E; Marino L; D'Elios MM
    J Infect Dev Ctries; 2011 Sep; 5(9):628-39. PubMed ID: 21918303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection.
    Dhariwala MO; Olson RM; Anderson DM
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28847850
    [No Abstract]   [Full Text] [Related]  

  • 4. Innate immune response during Yersinia infection: critical modulation of cell death mechanisms through phagocyte activation.
    Bergsbaken T; Cookson BT
    J Leukoc Biol; 2009 Nov; 86(5):1153-8. PubMed ID: 19734471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Opsonization Enhances Early Interactions between Yersinia pestis and Neutrophils in the Skin and Draining Lymph Node in a Mouse Model of Bubonic Plague.
    Shannon JG; Hinnebusch BJ
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune defense against pneumonic plague.
    Smiley ST
    Immunol Rev; 2008 Oct; 225():256-71. PubMed ID: 18837787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.
    Vagima Y; Zauberman A; Levy Y; Gur D; Tidhar A; Aftalion M; Shafferman A; Mamroud E
    PLoS Pathog; 2015 May; 11(5):e1004893. PubMed ID: 25974210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of
    Dudte SC; Hinnebusch BJ; Shannon JG
    Front Cell Infect Microbiol; 2017; 7():358. PubMed ID: 28848716
    [No Abstract]   [Full Text] [Related]  

  • 9. Yersinia pestis versus Yersinia pseudotuberculosis: effects on host macrophages.
    Bi Y; Wang X; Han Y; Guo Z; Yang R
    Scand J Immunol; 2012 Dec; 76(6):541-51. PubMed ID: 22882408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yersinia pestis survival and replication within human neutrophil phagosomes and uptake of infected neutrophils by macrophages.
    Spinner JL; Winfree S; Starr T; Shannon JG; Nair V; Steele-Mortimer O; Hinnebusch BJ
    J Leukoc Biol; 2014 Mar; 95(3):389-98. PubMed ID: 24227798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yersinia pestis subverts the dermal neutrophil response in a mouse model of bubonic plague.
    Shannon JG; Hasenkrug AM; Dorward DW; Nair V; Carmody AB; Hinnebusch BJ
    mBio; 2013 Aug; 4(5):e00170-13. PubMed ID: 23982068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
    Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E
    Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells.
    Kerschen EJ; Cohen DA; Kaplan AM; Straley SC
    Infect Immun; 2004 Aug; 72(8):4589-602. PubMed ID: 15271919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Neutrophil Primary Granule Release during Yersinia pestis Pulmonary Infection.
    Eichelberger KR; Jones GS; Goldman WE
    mBio; 2019 Dec; 10(6):. PubMed ID: 31822588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plague bacteria target immune cells during infection.
    Marketon MM; DePaolo RW; DeBord KL; Jabri B; Schneewind O
    Science; 2005 Sep; 309(5741):1739-41. PubMed ID: 16051750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages.
    Noel BL; Lilo S; Capurso D; Hill J; Bliska JB
    Clin Vaccine Immunol; 2009 Oct; 16(10):1457-66. PubMed ID: 19710295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early host cell targets of Yersinia pestis during primary pneumonic plague.
    Pechous RD; Sivaraman V; Price PA; Stasulli NM; Goldman WE
    PLoS Pathog; 2013; 9(10):e1003679. PubMed ID: 24098126
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Connor MG; Pulsifer AR; Chung D; Rouchka EC; Ceresa BK; Lawrenz MB
    mBio; 2018 Feb; 9(1):. PubMed ID: 29463656
    [No Abstract]   [Full Text] [Related]  

  • 19. Host transcriptomic responses to pneumonic plague reveal that Yersinia pestis inhibits both the initial adaptive and innate immune responses in mice.
    Yang H; Wang T; Tian G; Zhang Q; Wu X; Xin Y; Yan Y; Tan Y; Cao S; Liu W; Cui Y; Yang R; Du Z
    Int J Med Microbiol; 2017 Jan; 307(1):64-74. PubMed ID: 27876297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils.
    Lukaszewski RA; Kenny DJ; Taylor R; Rees DG; Hartley MG; Oyston PC
    Infect Immun; 2005 Nov; 73(11):7142-50. PubMed ID: 16239508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.